Using an orthogonal expression-based approach, PBRM1 mutated ccRCC tumors were enriched in a non-inflamed cluster, while BAP1 mutated tumors were enriched in an immune cell-inflamed cluster52. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.